Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Auld

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Assay and Drug Development Technologies|November 28, 2008
A robotic platform for quantitative high-throughput screeningSam Michael, Douglas Auld, Carleen Klumpp, et al.
JALA (Charlottesville, Va.)|May 23, 2008
Compound Management for Quantitative High-Throughput ScreeningAdam Yasgar, Paul Shinn, Ajit Jadhav, et al.
Journal of the American Chemical Society|January 30, 2018
Potent and Selective Inhibitors of 8-Oxoguanine DNA GlycosylaseYu-Ki Tahara, Douglas Auld, Debin Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher diseaseWei Zheng, Janak Padia, Daniel J Urban, et al.
Cell Chemical Biology|June 15, 2021
Identification and validation of selective deubiquitinase inhibitorsAnthony C Varca, Dominick Casalena, Wai Cheung Chan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Phenotypic screening for small molecules that lower PrP in cultured cellsJeannine A Frei, Andrew G Reidenbach, Leo Mh Xu, et al.
Ebiomedicine|July 19, 2016
A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and GeneticsKirsten Tschapalda, Ya-Qin Zhang, Li Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptorPetra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Journal of Medicinal Chemistry|November 3, 2020
Evolution of Novartis' Small Molecule Screening Deck DesignAnsgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell deathDerek S Welsbie, Zhiyong Yang, Yan Ge, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Assay and Drug Development Technologies|November 28, 2008
A robotic platform for quantitative high-throughput screeningSam Michael, Douglas Auld, Carleen Klumpp, et al.
JALA (Charlottesville, Va.)|May 23, 2008
Compound Management for Quantitative High-Throughput ScreeningAdam Yasgar, Paul Shinn, Ajit Jadhav, et al.
Journal of the American Chemical Society|January 30, 2018
Potent and Selective Inhibitors of 8-Oxoguanine DNA GlycosylaseYu-Ki Tahara, Douglas Auld, Debin Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher diseaseWei Zheng, Janak Padia, Daniel J Urban, et al.
Cell Chemical Biology|June 15, 2021
Identification and validation of selective deubiquitinase inhibitorsAnthony C Varca, Dominick Casalena, Wai Cheung Chan, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Phenotypic screening for small molecules that lower PrP in cultured cellsJeannine A Frei, Andrew G Reidenbach, Leo Mh Xu, et al.
Ebiomedicine|July 19, 2016
A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and GeneticsKirsten Tschapalda, Ya-Qin Zhang, Li Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptorPetra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Journal of Medicinal Chemistry|November 3, 2020
Evolution of Novartis' Small Molecule Screening Deck DesignAnsgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell deathDerek S Welsbie, Zhiyong Yang, Yan Ge, et al.
Pageof 3